Integrated Biosciences has a new Chief Scientific Officer (CSO), naming Daniel J. Anderson, PhD, to the post. Anderson joins ...

BioMed X, a pharmaceutical innovation hub, is partnering with the government of Barbados on research for AI-enabled therapy.

Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...

Astoriom, a leader in scientific research and consumer product sample stability and biorepository storage, has acquired Precision Stability Storage.

To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

ICON plc is expanding its oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois.

VoxCell, a Canadian biotechnology company advancing high-resolution, vascularized 3D tissue models, has appointed Graham Craig as Chief Commercial Officer (CCO).

OrganBio, an innovator in intelligent cell manufacturing, has appointed Karol Jarzabek as Chief Operating Officer.

Fortitude Biomedicines has launched following closing of $13 million in seed financing. Based in Waltham, Mass., the ...

Janux Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed William Go, M.D., Ph.D., as its Chief ...

MS Pharma Group has signed a strategic partnership agreement with Hetero Group to localize 5 established biosimilars across ...

Bora Biologics celebrated the opening of its expanded FDA-approved manufacturing facility in San Diego with a ribbon-cutting ...